Prevalence and Severity of HBV-Associated Acute-on-Chronic Liver Failure Due to Irregular Medication of Nucleos(t)ide Analogs

Prevalence and Severity of HBV-Associated Acute-on-Chronic Liver Failure Due to Irregular Medication of Nucleos(t)ide Analogs

Abstract. Hepatitis B virus (HBV) represents the commonest etiologic agent of acute-on-chronic liver failure (ACLF) in most Asian countries. Nucleos(t)ide analogs (NAs) are effective in the treatment of chronic HBV infections, but may also exacerbate the disease and stimulate its development into HB...

Full description

Bibliographic Details
Main Authors: Ying Zheng, Shu Chen, Yanxin Huang, Lisheng Jiang, Yongguo Li, Yinghua Lan, Shuchen Li, Yuqin Xu, Xiaodong Li, Hongwei Zhao, Yanbo Wang, Ying Shen, Chao Wei, Honglin Zhou, Rongshan Fan, Xiqiu Zeng, Mingxia Jiang, Shupeng Song, Mingyan Xu, Stijn van der Veen
Format: Article
Language:English
Published: Wolters Kluwer Health 2021-12-01
Series:Infectious Microbes & Diseases
Online Access:http://journals.lww.com/10.1097/IM9.0000000000000076

Internet

http://journals.lww.com/10.1097/IM9.0000000000000076

Similar Items